Case Reports
Treatment of severe acute respiratory syndrome with convalescent plasma
Affiliations
- PMID: 12777656
Item in Clipboard
Case Reports
Treatment of severe acute respiratory syndrome with convalescent plasma
Hong Kong Med J.
2003 Jun.
Free article
Abstract
In March 2003, an outbreak of severe acute respiratory syndrome started in Hong Kong. A 57-year-old woman had a typical presentation, including fever, non-productive cough, malaise, lymphopenia, and raised liver aminotransferases. The clinical course and successful treatment with convalescent plasma, ribavirin, and corticosteroids are discussed.
Comment in
-
Treatment of severe acute respiratory syndrome with convalescent plasma.Hong Kong Med J. 2003 Aug;9(4):309; author reply 310. Hong Kong Med J. 2003. PMID: 12904626 No abstract available.
-
Treating emerging viral infections.Hong Kong Med J. 2003 Aug;9(4):310; author reply 310. Hong Kong Med J. 2003. PMID: 12904627 No abstract available.
Similar articles
-
Treatment of severe acute respiratory syndrome.Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):583-91. doi: 10.1007/s10096-005-0004-z. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16172857 Free PMC article. Review.
-
Use of convalescent plasma therapy in SARS patients in Hong Kong.Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6. doi: 10.1007/s10096-004-1271-9. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15616839 Free PMC article.
-
Severe acute respiratory syndrome (SARS): epidemiology and clinical features.Postgrad Med J. 2004 Jul;80(945):373-81. doi: 10.1136/pgmj.2004.020263. Postgrad Med J. 2004. PMID: 15254300 Free PMC article. Review.
-
Treating emerging viral infections.Hong Kong Med J. 2003 Aug;9(4):310; author reply 310. Hong Kong Med J. 2003. PMID: 12904627 No abstract available.
-
Treatment of severe acute respiratory syndrome with convalescent plasma.Hong Kong Med J. 2003 Aug;9(4):309; author reply 310. Hong Kong Med J. 2003. PMID: 12904626 No abstract available.
Cited by
-
The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019.Infect Dis Immun. 2021 Apr 20;1(1):52-58. doi: 10.1097/01.ID9.0000733568.58627.47. eCollection 2021 Apr. Infect Dis Immun. 2021. PMID: 38630075 Free PMC article. Review.
-
Impact of the COVID-19 pandemic on blood donation and transfusions in the United States in 2020.Transfusion. 2023 Oct;63 Suppl 4(Suppl 4):S1-S7. doi: 10.1111/trf.17359. Epub 2023 Apr 13. Transfusion. 2023. PMID: 37052192 Free PMC article.
-
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications.Front Immunol. 2023 Jan 19;14:1055457. doi: 10.3389/fimmu.2023.1055457. eCollection 2023. Front Immunol. 2023. PMID: 36742320 Free PMC article. Review.
-
Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2-Characteristics of Intermediates and Final Product.Viruses. 2022 Jun 17;14(6):1328. doi: 10.3390/v14061328. Viruses. 2022. PMID: 35746798 Free PMC article.
-
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21. Int Immunopharmacol. 2022. PMID: 35483235 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
